Market revenue in 2023 | USD 10,458.3 million |
Market revenue in 2030 | USD 19,217.3 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 67.64% in 2023. Horizon Databook has segmented the Asia Pacific veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific market is expected to exhibit lucrative growth over the forecast period. This can be attributed to the increasing adoption of pet animals, growing health concerns, increasing vigilance about animal health, rising livestock population, and increasing prevalence of animal diseases.
Moreover, market growth in the region can be attributed to a significantly large cattle population. For instance, China & India constitute more than 30% of the global population of cattle. The large livestock population has enhanced the demand for meat & dairy production, which is expected to further boost the demand for veterinary medicines for livestock animals.
An increase in the number of veterinary hospitals and clinics in countries such as China is further boosting market growth. The region has a wide number of market players. These market players are involved in strategic partnerships, expansions, product launches, and others to cater to market demand.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account